November 2, 2026

Lina Irawan

Context Therapeutics Pivots Strategy, Halting CT-95 Development to Focus on Promising Bispecific Assets Amidst Financial Prudence context-therapeutics-pivots-strategy-halting-ct-95-development-to-focus-on-promising-bispecific-assets-amidst-financial-prudence

Context Therapeutics Pivots Strategy, Halting CT-95 Development to Focus on Promising Bispecific Assets Amidst Financial Prudence

Lina Irawan August 7, 2026
Philadelphia, PA – In a strategic recalibration driven by financial realities and evolving pipeline data, Context Therapeutics,...
Read More Read more about Context Therapeutics Pivots Strategy, Halting CT-95 Development to Focus on Promising Bispecific Assets Amidst Financial Prudence
Engineering the Future: How Sai Life Sciences is Revolutionizing Pharmaceutical Scale-Up Through Data-Rich Innovation engineering-the-future-how-sai-life-sciences-is-revolutionizing-pharmaceutical-scale-up-through-data-rich-innovation

Engineering the Future: How Sai Life Sciences is Revolutionizing Pharmaceutical Scale-Up Through Data-Rich Innovation

Lina Irawan August 7, 2026
The pharmaceutical industry has long been shackled by a paradox: as our biological understanding of disease reaches...
Read More Read more about Engineering the Future: How Sai Life Sciences is Revolutionizing Pharmaceutical Scale-Up Through Data-Rich Innovation
Revolutionizing Emergency Medicine: Micron Biomedical Secures $4.5M NIAID Contract for Needle-Free Radiation Countermeasures revolutionizing-emergency-medicine-micron-biomedical-secures-4-5m-niaid-contract-for-needle-free-radiation-countermeasures

Revolutionizing Emergency Medicine: Micron Biomedical Secures $4.5M NIAID Contract for Needle-Free Radiation Countermeasures

Lina Irawan August 5, 2026
In a significant leap for medical logistics and emergency response, Atlanta-based biotech innovator Micron Biomedical has been...
Read More Read more about Revolutionizing Emergency Medicine: Micron Biomedical Secures $4.5M NIAID Contract for Needle-Free Radiation Countermeasures
The Transformation of U.S. Global Health Policy: A Comprehensive Review of the Second Trump Administration the-transformation-of-u-s-global-health-policy-a-comprehensive-review-of-the-second-trump-administration

The Transformation of U.S. Global Health Policy: A Comprehensive Review of the Second Trump Administration

Lina Irawan August 3, 2026
Date of Original Publication: January 28, 2025 Last Updated: August 3, 2026 Since the first day of...
Read More Read more about The Transformation of U.S. Global Health Policy: A Comprehensive Review of the Second Trump Administration

You may have missed

landmark-uk-approval-paves-way-for-first-disease-modifying-therapy-for-rare-mitochondrial-disorder

Landmark UK Approval Paves Way for First Disease-Modifying Therapy for Rare Mitochondrial Disorder

Asep Darmawan November 2, 2026
beyond-philanthropy-forging-powerful-corporate-nonprofit-partnerships-for-mutual-growth-and-impact

Beyond Philanthropy: Forging Powerful Corporate-Nonprofit Partnerships for Mutual Growth and Impact

Laily UPN November 2, 2026
the-evolution-of-advocacy-dr-kelly-shanahan-and-the-changing-landscape-of-metastatic-breast-cancer-research

The Evolution of Advocacy: Dr. Kelly Shanahan and the Changing Landscape of Metastatic Breast Cancer Research

Nana Wu November 2, 2026
harnessing-intelligence-bcrf-symposium-to-showcase-ai-driven-revolution-in-breast-cancer-research

Harnessing Intelligence: BCRF Symposium to Showcase AI-Driven Revolution in Breast Cancer Research

Ali Ikhwan November 2, 2026